Wed, Jul 30, 2014, 5:39 AM EDT - U.S. Markets open in 3 hrs 51 mins

Recent

% | $
Click the to save as a favorite.

ImmunoCellular Therapeutics, Ltd. Message Board

  • bob_flemings bob_flemings Jul 24, 2012 10:42 AM Flag

    Today's article is quite good.

    Good and easy reading, folks. Brian's article focuses on ICT-107. I find that his style is easy to grasp.



    Sneak peek:

    The reason it is so important for a vaccine to target several antigens is because cancer has the ability to quickly mutate, and even if destroyed, it can come back stronger and in other parts of the body. The "one antigen approach" may work in treating the cancer, but if the cancer evolves or begins to express another antigen then a treatment becomes less effective or even ineffective if it mutates and no longer expresses the original targeted antigen. IMUC's ICT-107 targets the cancer from multiple points, and prevents it from metastasizing into other cancers of the body, therefore blocking many avenues for the cancer to evolve.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
IMUC
0.99+0.01(+1.02%)Jul 29 4:02 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.